It is a pharma private limited company based in Pune City, Maharashtra, India, established in 2022.
2022 | Pune City, Maharashtra, India | ActiveNew Amar Pharmaceuticals Private Limited, a active private limited company, was established on 07 March 2022 in Pune City, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909PN2022PTC241664. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹5.20 Cr and a paid-up capital of ₹5.01 Cr.
It upholds a compliant status. Employing 279 professional, Its leadership includes Arvind Kumar Venkat (Director), Yaaresh Gilan Ferzandi (Director), Nilesh Sohanlal Sonigara (Managing Director). Past directors included Arvind Kumar Venkat, Nilesh Sohanlal Sonigara, Gaurav Chaturvedi. It holds ₹34.53 Cr open charges and no settled loans. Its latest AGM occurred on 03 July 2025, with the balance sheet filed on 31 March 2025. It is based at Sn-22/3, Nr Deep Vandan, Karyalaya, Katraj, Pune, Pune City, Maharashtra, 411046.
U51909PN2022PTC241664
241664
07 March 2022
₹5.20 Cr
₹5.01 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into New Amar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Kumar Venkat | Director | 10 Mar 2025 | Current |
| Yaaresh Gilan Ferzandi | Director | 07 Mar 2022 | Current |
| Nilesh Sohanlal Sonigara | Managing Director | 27 Jul 2022 | Current |
| Gilan Plumarz Ferzandi | Director | 07 Mar 2022 | Current |
| Gaurav Chaturvedi | Director | 09 Jan 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 02 Jul 2025 | Past |
| Pramod Abcsdd | Additional Director | 22 Aug 2023 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to New Amar Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹345,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2024 | Hdfc Bank Limited | ₹33.00 Cr | Open |
| 01 Dec 2023 | Hdfc Bank Limited | ₹1.53 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with New Amar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of New Amar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Amar Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on New Amar Pharmaceuticals Private Limited last Annual general meeting of members was held on 03 Jul 2025 as per latest MCA records. was documented.
New Amar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.
The activity Arvind Kumar Venkat was appointed as a Director was appointed as a Director on 10 Mar 2025 & has been associated with this company since 8 months 19 days . was completed.
The activity A charge with Hdfc Bank Limited of Rs. 33.00 Cr registered on 16 Mar 2024 with Charge ID 100886464 was modified on 15 Jun 2024. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 33.00 Cr with Charge ID 100886464 was registered on 16 Mar 2024. was documented.
Gaurav Chaturvedi was appointed as a Director was appointed as a Director on 09 Jan 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
The CIN of New Amar Pharmaceuticals Private Limited is U51909PN2022PTC241664.
New Amar Pharmaceuticals Private Limited is headquartered at Sn-22/3, Nr Deep Vandan, Karyalaya, Katraj, Pune, Pune City, Maharashtra, 411046.
New Amar Pharmaceuticals Private Limited was incorporated on 07 March 2022.
The current directors of New Amar Pharmaceuticals Private Limited are
The primary industry of New Amar Pharmaceuticals Private Limited is Trade.
New Amar Pharmaceuticals Private Limited is unlisted.
The authorized capital of New Amar Pharmaceuticals Private Limited is ₹5.20 Cr, and the paid-up capital is ₹5.01 Cr.
The compliance status of New Amar Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX